李泽钜:长和(00001.HK)资产抗跌力强 按计划逐步进行回购
长和(00001.HK)主席李泽钜於股东周年大会上表示,新冠疫情对公司业务犹如压力测试,而结果显示公司资产抗跌能力强,尤其码头及零售表现已回升,电讯业务亦表现稳定。对於并购上,他指任何对股东有利的项目均会考虑,亦已有业务范围内物色并购项目。
集团联席董事总经理霍建宁表示,今年首季欧洲电讯业收入及毛利按年维持相若水平,反映抗跌能力良好。香港5G业务方面,与丰泽、百佳及屈臣氏合作後,有关销售点已由约20至30个增至300个。
至於股份回购方面,李泽钜称回购是一个长期的计划,将视乎市况及公司融资安排等,按计划逐步进行。
李泽钜又指出,和黄医药暂无上市时间表,继续留意市况,评估会否在港或其他地区上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.